Bliss GVS Pharma fundamental analysis

BLISSGVS

216.57

0.96 (0.45%)
Last updated on 5 Mar, 2026 | 15:58 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bliss GVS Pharma Fundamentals

P/E Ratio

20.93

P/B Ratio

1.97

Div. Yield

0.23

Sector P/E

61.2

Sector P/B

2.65

Sec. Div. Yield

0.58

Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 20.93, compared to the sector average of 61.2. Its P/B Ratio stands at 1.97, while the sector’s is 2.65. In terms of returns, the stock offers a Dividend Yield of 0.23%, which is than the sector’s 0.58%.

Bliss GVS Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Average

On its scorecard, Bliss GVS Pharma reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost